Back to Search
Start Over
Unequivocal identification of an underestimated opportunistic yeast species, Cyberlindnera fabianii, and its close relatives using a dual-function PCR and literature review of published cases
- Source :
- Medical Mycology, 57(7). Informa Healthcare, Medical Mycology, Medical Mycology. Informa Healthcare
- Publication Year :
- 2019
-
Abstract
- Although Cyberlindnera fabinaii is a rare opportunist yeast species, its ability to cause septicemia, produce biofilm, and rapid acquisition of resistance to fluconazole and voriconazole, reinforced the urge for its identification from its closely related species. Widely used biochemical assays mainly identify Cyberlindnera fabinaii as Cyberlindnera jadinii and Wickerhamomyces anomalus, resulting in underestimation of this yeast in clinical settings. Moreover, the urge for a reliable molecular means of identification remains unsolved for 28 years. In order to unequivocally differentiate Cy. fabianii, Cy. mississipiensis, Cy. jadinii, and W. anomalus, we designed a dual-function multiplex polymerase chain reaction (PCR) assay. Challenging our dual-function multiplex PCR assay with 30 most clinically important yeast species, proved its specificity. Although conventional PCR could differentiate four target species, the real-time PCR counterpart due to Tm overlap misidentified Cy. mississipiensis as Cy. jadinii. Alongside of presenting a comprehensive literature review of published cases of Cy. fabianii from 1990 to 2018, we collected various clinical isolates from Tehran, Shiraz, and Fasa (July 1, 2017, to December 31, 2017) to find a passive relative distribution of these closely-related species in Iran. Subjecting our Iranian collection of yeast isolates to matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) MS and LSU and ITS rDNA sequencng revealed six isolates of Cy. fabianii (central venous catheter n = 2 and vaginal swabs n = 4) and one isolate of Cy. jadinii (vaginal swabs). Due to the use of biochemical assays in global ARTEMIS study, we encourage reidentification of clinical isolates of Cy. jadinii and Cy. jadinii using MALDI-TOF or Sanger sequencing that might lead to correcting the distribution of this fungus.
- Subjects :
- Male
0301 basic medicine
Antifungal Agents
030106 microbiology
Cy. mississipiensis
Iran
DNA, Ribosomal
Sensitivity and Specificity
03 medical and health sciences
0302 clinical medicine
Humans
030212 general & internal medicine
DNA Primers
2. Zero hunger
Cy. jadinii
biochemical assays
General Medicine
multiplex PCR
Cy. fabianii
3. Good health
Infectious Diseases
W. anomalus
Mycoses
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Saccharomycetales
Vagina
Female
Original Article
Corrigendum
Multiplex Polymerase Chain Reaction
Subjects
Details
- Language :
- English
- ISSN :
- 13693786
- Volume :
- 57
- Issue :
- 7
- Database :
- OpenAIRE
- Journal :
- Medical Mycology
- Accession number :
- edsair.doi.dedup.....009b6f1765b194d6eb4c13dd906aabb2